AMP
Association for Molecular Pathology Issues Guidelines to Promote Genetic Variant Data Sharing
The group drafted a series of recommendations for key stakeholders including clinical labs, database operations, policymakers, and researchers.
AMP-led Expert Groups Release Clinical CYP2D6 Pharmacogenomic Testing Recommendation
The consensus guideline offers a two-tier categorization of alleles that are recommended for clinical CYP2D6 pharmacogenetic testing.
AMP Cautions Against Using Cycle Threshold Values for PCR SARS-CoV-2 Tests in Clinical Practice
Although a cycle threshold value may help determine patient prognosis and risk of transmission, there is limited data on making clinical decisions based on Ct values, AMP said.
New AMP Survey Reports Insufficient Reimbursement for Analysis, Interpretation of MDx Test Results
The survey found analysis, interpretation, and reporting requirements can take more than six hours per test but that reimbursement for tests doesn't account for this work.
AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic
Laboratory staffing and supply shortages limited patient access to cancer screening tests, and the pandemic decreased the development and validation of new tests.